Gland Pharma Ltd.

Gland Pharma Ltd.

Maintaining A Healthy Edge

With its particular acclaim for sterile injectables, oncology and ophthalmic products, the company has begun to reinforce its position on the international stage by venturing into markets like Saudi Arabia, Singapore, Israel and CIS regions. This will surely reap rich dividends.

Rate this article:
3.8

Leave a comment

Add comment
 

DSIJ MINDSHARE

Mkt Commentary8-May, 2024

Multibaggers8-May, 2024

Multibaggers8-May, 2024

Multibaggers8-May, 2024

Multibaggers8-May, 2024

Knowledge

General8-May, 2024

Technical4-May, 2024

Fundamental3-May, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR